The company reported $1.4 million in worldwide orthopedics sales, which was slightly below the $1.5 million reported in the first quarter of 2011. The company’s international orthopedics sales increased 2.6 percent, which offset a decrease in the U.S. market.
During the first quarter, the company reported $271 million in expenses related to litigation and the DePuy ASC Hip recall costs.
More Articles on Orthopedic Devices:
Johnson & Johnson’s Synthes Acquisition Finally Approved
NLT Spine Receives CE Mark for Discectomy Device
Stryker Q1 Sales Soar 7.2%, Spine Sales Driven by Acquisitions
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.